Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia

Fundamental and Clinical Pharmacology

Volumn 27, Issue 3, 2013, Pages 252-261

  Ramond, Amandine ^a   Godin Ribuot, Diane ^a   Ribuot, Christophe ^a   Totoson, Perle ^a   Koritchneva, Irina ^a   Cachot, Sandrine ^a   Levy, Patrick ^a,b   Joyeux Faure, Marie ^a  

^a Domaine de la Merci   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Intermittent hypoxia; Melatonin; Myocardial infarction; Oxidative stress; Rats; Tempol

Indexed keywords

MELATONIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR EFFECT; CHRONIC INTERMITTENT HYPOXIA; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE EXACERBATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; HEART VENTRICLE FUNCTION; HEMATOCRIT; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

ANIMALS; ANOXIA; ANTIOXIDANTS; ARTERIAL PRESSURE; CYCLIC N-OXIDES; ETHIDIUM; MALE; MELATONIN; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NADP; NADPH OXIDASE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SPIN LABELS;

EID: 84877829165     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2011.01015.x     Document Type: Article

References (45)

1. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S.The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. (1993) 328 1230-1235.
2. McNicholas W.T., Bonsigore M.R.Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur. Respir. J. (2007) 29 156-178.
3. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G.Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet (2005) 365 1046-1053.
4. Punjabi N.M., Caffo B.S., Goodwin J.L. et al.Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. (2009) 6 e1000132.
5. Duran-Cantolla J., Aizpuru F., Martinez-Null C., Barbe-Illa F.Obstructive sleep apnea/hypopnea and systemic hypertension. Sleep Med Rev. (2009) 13 323-331.
6. Peker Y., Hedner J., Kraiczi H., Loth S.Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am. J. Respir. Crit. Care Med. (2000) 162 81-86.
7. Arzt M., Young T., Finn L., Skatrud J.B., Bradley T.D.Association of sleep-disordered breathing and the occurrence of stroke. Am. J. Respir. Crit. Care Med. (2005) 172 1447-1451.
8. Yaggi H.K., Concato J., Kernan W.N., Lichtman J.H., Brass L.M., Mohsenin V.Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med. (2005) 353 2034-2041.
9. Nakashima H., Katayama T., Takagi C. et al.Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction. Eur. Heart J. (2006) 27 2317-2322.
10. Lavie L., Lavie P.Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur. Respir. J. (2009) 33 1467-1484.
11. Morgan B.J.Vascular consequences of intermittent hypoxia. Adv. Exp. Med. Biol. (2007) 618 69-84.
12. Dematteis M., Godin-Ribuot D., Arnaud C. et al.Cardiovascular consequences of sleep-disordered breathing: contribution of animal models to understanding the human disease. ILAR J. (2009) 50 262-281.
13. Julien C., Bayat S., Levy P.Vascular reactivity to norepinephrine and acetylcholine after chronic intermittent hypoxia in mice. Respir. Physiol. Neurobiol. (2003) 139 21-32.
14. Lefebvre B., Godin-Ribuot D., Joyeux-Faure M. et al.Functional assessment of vascular reactivity after chronic intermittent hypoxia in the rat. Respir. Physiol. Neurobiol. (2006) 150 278-286.
15. Belaidi E., Ramond A., Joyeux-Faure M., Levy P., Ribuot C., Godin-Ribuot D.. Contrasting effects of intermittent hypoxia on myocardial ischemic tolerance, Nova Science Publishers Inc., New York, 2009.
16. Joyeux-Faure M., Stanke-Labesque F., Lefebvre B. et al.Chronic intermittent hypoxia increases infarction in the isolated rat heart. J. Appl. Physiol. (2005) 98 1691-1696.
17. Belaidi E., Joyeux-Faure M., Ribuot C., Launois S.H., Levy P., Godin-Ribuot D.Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J. Am. Coll. Cardiol. (2009) 53 1309-1317.
18. Dopp J.M., Philippi N.R., Marcus N.J. et al.Xanthine oxidase inhibition attenuates endothelial dysfunction caused by chronic intermittent hypoxia in rats. Respiration (2011) 82 458-467.
19. Kohler M., Stradling J.R.Mechanisms of vascular damage in obstructive sleep apnea. Nat. Rev. Cardiol. (2010) 7 677-685.
20. Schnackenberg C.G., Wilcox C.S.Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha. Hypertension (1999) 33 424-428.
21. Troncoso Brindeiro C.M., da Silva A.Q., Allahdadi K.J., Youngblood V., Kanagy N.L.Reactive oxygen species contribute to sleep apnea-induced hypertension in rats. Am. J. Physiol. Heart Circ. Physiol. (2007) 293 H2971-H2976.
22. McDonald M.C., Zacharowski K., Bowes J., Cuzzocrea S., Thiemermann C.Tempol reduces infarct size in rodent models of regional myocardial ischemia and reperfusion. Free Radic. Biol. Med. (1999) 27 493-503.
23. Hardeland R.Melatonin, hormone of darkness and more: occurrence, control mechanisms, actions and bioactive metabolites. Cell. Mol. Life Sci. (2008) 65 2001-2018.
24. Gilad E., Cuzzocrea S., Zingarelli B., Salzman A.L., Szabo C.Melatonin is a scavenger of peroxynitrite. Life Sci. (1997) 60 PL169-PL174.
25. Cuzzocrea S., Zingarelli B., Gilad E., Hake P., Salzman A.L., Szabo C.Protective effect of melatonin in carrageenan-induced models of local inflammation: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. J. Pineal Res. (1997) 23 106-116.
26. Pieri C., Marra M., Moroni F., Recchioni R., Marcheselli F.Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci. (1994) 55 PL271-PL276.
27. Reiter R., Tang L., Garcia J.J., Munoz-Hoyos A.Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci. (1997) 60 2255-2271.
28. Antolin I., Rodriguez C., Sainz R.M. et al.Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J. (1996) 10 882-890.
29. Lagneux C., Joyeux M., Demenge P., Ribuot C., Godin-Ribuot D.Protective effects of melatonin against ischemia-reperfusion injury in the isolated rat heart. Life Sci. (2000) 66 503-509.
30. Leon J., Acuna-Castroviejo D., Sainz R.M., Mayo J.C., Tan D.X., Reiter R.J.Melatonin and mitochondrial function. Life Sci. (2004) 75 765-790.
31. Petrosillo G., Colantuono G., Moro N. et al.Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am. J. Physiol. Heart Circ. Physiol. (2009) 297 H1487-H1493.
32. Hausenloy D.J., Yellon D.M.The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J. Mol. Cell. Cardiol. (2003) 35 339-341.
33. Yeung H.M., Hung M.W., Fung M.L.Melatonin ameliorates calcium homeostasis in myocardial and ischemia-reperfusion injury in chronically hypoxic rats. J. Pineal Res. (2008) 45 373-382.
34. Umeji K., Umemoto S., Itoh S. et al.Comparative effects of pitavastatin and probucol on oxidative stress, Cu/Zn superoxide dismutase, PPAR-gamma, and aortic stiffness in hypercholesterolemia. Am. J. Physiol. Heart Circ. Physiol. (2006) 291 H2522-H2532.
35. Mariappan N., Elks C.M., Fink B., Francis J.TNF-induced mitochondrial damage: a link between mitochondrial complex I activity and left ventricular dysfunction. Free Radic. Biol. Med. (2009) 46 462-470.
36. Duda M., Konior A., Klemenska E., Beresewicz A.Preconditioning protects endothelium by preventing ET-1-induced activation of NADPH oxidase and xanthine oxidase in post-ischemic heart. J. Mol. Cell. Cardiol. (2007) 42 400-410.
37. Guo P., Nishiyama A., Rahman M. et al.Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade. J. Hypertens. (2006) 24 1097-1104.
38. Gao L., Wang W., Li Y.L. et al.Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ. Res. (2004) 95 937-944.
39. Paradies G., Petrosillo G., Paradies V., Reiter R.J., Ruggiero F.M.Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J. Pineal Res. (2010) 48 297-310.
40. Petrosillo G., Ruggiero F.M., Di Venosa N., Paradies G.Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin. FASEB J. (2003) 17 714-716.
41. Fulia F., Gitto E., Cuzzocrea S. et al.Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J. Pineal Res. (2001) 31 343-349.
42. Sahna E., Parlakpinar H., Turkoz Y., Acet A.Protective effects of melatonin on myocardial ischemia/reperfusion induced infarct size and oxidative changes. Physiol. Res. (2005) 54 491-495.
43. Lochner A., Genade S., Moolman J.A.Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery. Basic Res. Cardiol. (2003) 98 337-346.
44. Lavie L., Vishnevsky A., Lavie P.Evidence for lipid peroxidation in obstructive sleep apnea. Sleep (2004) 27 123-128.
45. Monneret D., Pepin J.L., Godin-Ribuot D. et al.Association of urinary 15-F2t-isoprostane level with oxygen desaturation and carotid intima-media thickness in nonobese sleep apnea patients. Free Radic. Biol. Med. (2010) 48 619-625.